Dermatokinetic assessment of luliconazole-loaded nanostructured lipid carriers (NLCs) for topical delivery: QbD-driven design, optimization, and in vitro and ex vivo evaluations
暂无分享,去创建一个
[1] A. Alexander,et al. Solid lipid nanocarriers embedded hydrogel for topical delivery of apremilast: In-vitro, ex-vivo, dermatopharmacokinetic and anti-psoriatic evaluation , 2021 .
[2] Gautam Singhvi,et al. Luliconazole loaded lyotropic liquid crystalline nanoparticles for topical delivery: QbD driven optimization, in-vitro characterization and Dermatokinetic assessment. , 2020, Chemistry and physics of lipids.
[3] Gautam Singhvi,et al. Improved skin-permeated diclofenac-loaded lyotropic liquid crystal nanoparticles: QbD-driven industrial feasible process and assessment of skin deposition , 2020 .
[4] S. Dubey,et al. Psoriasis: pathological mechanisms, current pharmacological therapies, and emerging drug delivery systems. , 2020, Drug discovery today.
[5] S. Dubey,et al. Insights of lyotropic liquid crystals in topical drug delivery for targeting various skin disorders , 2020 .
[6] Alejandro J. Paredes,et al. Microarray Patches: Poking a Hole in the Challenges Faced When Delivering Poorly Soluble Drugs , 2020, Advanced Functional Materials.
[7] Mitsuru Sugawara,et al. European Journal of Pharmaceutics and Biopharmaceutics. , 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[8] Alejandro J. Paredes,et al. Dissolving Microneedle-Mediated Dermal Delivery of Itraconazole Nanocrystals for Improved Treatment of Cutaneous Candidiasis. , 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[9] D. Chellappan,et al. Emerging role of nanocarriers based topical delivery of anti‐fungal agents in combating growing fungal infections , 2020, Dermatologic therapy.
[10] A. Puri,et al. Nanostructured Lipid Carriers as Potential Drug Delivery Systems for Skin disorders. , 2020, Current pharmaceutical design.
[11] S. Dubey,et al. UV spectrophotometric method for simultaneous estimation of betamethasone valerate and tazarotene with absorption factor method: Application for in-vitro and ex-vivo characterization of lipidic nanocarriers for topical delivery. , 2020, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[12] L. Kumar,et al. Novel drug delivery system of luliconazole - Formulation and characterisation , 2020 .
[13] Harpreet Singh,et al. Chemistry and Pharmacology of Luliconazole (Imidazole Derivative): A Novel Bioactive Compound to Treat Fungal Infection-A Mini Review , 2020 .
[14] Ameeduzzafar,et al. BBD-Based Development of Itraconazole Loaded Nanostructured Lipid Carrier for Topical Delivery: In Vitro Evaluation and Antimicrobial Assessment , 2020, Journal of Pharmaceutical Innovation.
[15] M. M. Pandey,et al. UV Spectrophotometric method for characterization of curcumin loaded nanostructured lipid nanocarriers in simulated conditions: Method development, in-vitro and ex-vivo applications in topical delivery. , 2020, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[16] P. Sharma,et al. Optimization and characterization of rivastigmine nanolipid carrier loaded transdermal patches for the treatment of dementia. , 2019, Chemistry and physics of lipids.
[17] Sravanthi Reddy Pailla,et al. Fabrication of Ibrutinib Nanosuspension by Quality by Design Approach: Intended for Enhanced Oral Bioavailability and Diminished Fast Fed Variability , 2019, AAPS PharmSciTech.
[18] A. Nayak,et al. Stability indicating liquid chromatographic method for simultaneous quantification of betamethasone valerate and tazarotene in in-vitro and ex-vivo studies of complex nanoformulation. , 2019, Journal of separation science.
[19] S. Dubey,et al. Nanocarriers for Topical Drug Delivery: Approaches and Advancements , 2019, Nanoscience & Nanotechnology-Asia.
[20] A. Nayak,et al. Voriconazole loaded nanostructured lipid carriers based topical delivery system: QbD based designing, characterization, in-vitro and ex-vivo evaluation , 2019, Journal of Drug Delivery Science and Technology.
[21] M. H. Santana,et al. Evaluation of the Influence of Process Parameters on the Properties of Resveratrol-Loaded NLC Using 22 Full Factorial Design , 2019, Antioxidants.
[22] Shashank Soni,et al. Preparation of luliconazole nanocrystals loaded hydrogel for improvement of dissolution and antifungal activity , 2019, Heliyon.
[23] C. Mansur,et al. Size and Vitamin E Release of Nanostructured Lipid Carriers with Different Liquid Lipids, Surfactants and Preparation Methods , 2019, Macromolecular Symposia.
[24] C. Cho,et al. Development and evaluation of a film-forming system hybridized with econazole-loaded nanostructured lipid carriers for enhanced antifungal activity against dermatophytes. , 2019, Acta biomaterialia.
[25] Sunil Kumar,et al. Emerging nanoparticulate systems: Preparation techniques and stimuli responsive release characteristics , 2019, Journal of Applied Pharmaceutical Science.
[26] Vamshi Krishna Rapalli,et al. Application of QbD Principles in Nanocarrier-Based Drug Delivery Systems , 2019 .
[27] G. Gupta,et al. MicroRNAs as biological regulators in skin disorders. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[28] Gautam Singhvi,et al. Nanocarriers For Drug Delivery: Mini Review , 2018, Current Nanomedicine.
[29] D. Chellappan,et al. Emerging landscape in psoriasis management: From topical application to targeting biomolecules. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[30] I. Kaur,et al. Topical delivery of tetrahydrocurcumin lipid nanoparticles effectively inhibits skin inflammation: in vitro and in vivo study , 2018, Drug development and industrial pharmacy.
[31] M. Amaral,et al. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[32] E. Bendas,et al. Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study , 2017, Drug delivery.
[33] Gautam Singhvi,et al. Lyotropic liquid crystal nanoparticles: A novel improved lipidic drug delivery system , 2018 .
[34] M. Misran,et al. Rheological and physicochemical characterization of alpha-tocopherol loaded lipid nanoparticles in thermoresponsive gel for topical application , 2017 .
[35] V. Junyaprasert,et al. Influence of state and crystallinity of lipid matrix on physicochemical properties and permeation of capsaicin-loaded lipid nanoparticles for topical delivery , 2017 .
[36] N. Thotakura,et al. Dermatokinetics as an Important Tool to Assess the Bioavailability of Drugs by Topical Nanocarriers. , 2017, Current drug metabolism.
[37] Gajanand Sharma,et al. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s). , 2017, International journal of pharmaceutics.
[38] Sabine Szunerits,et al. Transdermal skin patch based on reduced graphene oxide: A new approach for photothermal triggered permeation of ondansetron across porcine skin , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[39] Ajay Kumar,et al. Efavirenz Self-Nano-Emulsifying Drug Delivery System: In Vitro and In Vivo Evaluation , 2016, AAPS PharmSciTech.
[40] S. Mallick,et al. Microemulsion-based antifungal gel of luliconazole for dermatophyte infections: formulation, characterization and efficacy studies , 2016, Journal of Pharmaceutical Investigation.
[41] V. Pokharkar,et al. Quality by design approach to understand the process of optimization of iloperidone nanostructured lipid carriers for oral bioavailability enhancement , 2015, Pharmaceutical development and technology.
[42] P. Vavia,et al. Rivastigmine-loaded in situ gelling nanostructured lipid carriers for nose to brain delivery , 2015, Journal of liposome research.
[43] A. Zimmer,et al. Solvent-Free Melting Techniques for the Preparation of Lipid-Based Solid Oral Formulations , 2015, Pharmaceutical Research.
[44] Geoffrey Lee,et al. Saturation solubility of nicotine, scopolamine and paracetamol in model stratum corneum lipid matrices. , 2014, International journal of pharmaceutics.
[45] A. C. Silva,et al. Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity. , 2013, Colloids and surfaces. B, Biointerfaces.
[46] J. Sousa,et al. Co-encapsulating nanostructured lipid carriers for transdermal application: from experimental design to the molecular detail. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[47] Sacheen Kumar,et al. High melting lipid based approach for drug delivery: solid lipid nanoparticles. , 2013, Materials science & engineering. C, Materials for biological applications.
[48] Bhupinder Singh,et al. Nanocolloidal carriers of isotretinoin: antimicrobial activity against Propionibacterium acnes and dermatokinetic modeling. , 2013, Molecular pharmaceutics.
[49] P. Vavia,et al. Nanolipidgel for Enhanced Skin Deposition and Improved Antifungal Activity , 2013, AAPS PharmSciTech.
[50] Ran Yin,et al. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation. , 2012, International journal of pharmaceutics.
[51] H. Bunjes. Structural properties of solid lipid based colloidal drug delivery systems , 2011 .
[52] I. Kaur,et al. Topical delivery of antifungal agents , 2010, Expert opinion on drug delivery.
[53] R. Patlolla,et al. Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery , 2010, Molecular membrane biology.
[54] A. Deep,et al. Development and characterization of nanoparticles of glibenclamide by solvent displacement method. , 2010, Acta poloniae pharmaceutica.
[55] Chi-Hsien Liu,et al. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[56] Kumar A. Shah,et al. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. , 2007, International journal of pharmaceutics.
[57] H. Yamaguchi,et al. In vitro antifungal activity of luliconazole (NND-502), a novel imidazole antifungal agent , 2004, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[58] R. Müller,et al. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. , 2002, Advanced drug delivery reviews.
[59] R. Müller,et al. Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[60] L. Ajello. A taxonomic review of the dermatophytes and related species. , 1968, Sabouraudia.